Upgrades
For Banco Santander SA (NYSE:SAN), Credit Suisse upgraded the previous rating of Neutral to Outperform. Banco Santander earned $0.14 in the fourth quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.38 and a 52-week-low of $2.77. Banco Santander closed at $3.38 at the end of the last trading period.
Goldman Sachs upgraded the previous rating for Comerica Inc (NYSE:CMA) from Sell to Neutral. In the fourth quarter, Comerica showed an EPS of $1.66, compared to $1.49 from the year-ago quarter. At the moment, the stock has a 52-week-high of $102.09 and a 52-week-low of $63.07. Comerica closed at $90.43 at the end of the last trading period.
According to Stifel, the prior rating for Centennial Resource Development Inc (NASDAQ:CDEV) was changed from Hold to Buy. For the fourth quarter, Centennial Resource Dev had an EPS of $0.51, compared to year-ago quarter EPS of $0.32. The current stock performance of Centennial Resource Dev shows a 52-week-high of $9.30 and a 52-week-low of $3.69. Moreover, at the end of the last trading period, the closing price was at $8.07.
According to JP Morgan, the prior rating for Comerica Inc (NYSE:CMA) was changed from Neutral to Overweight. Comerica earned $1.66 in the fourth quarter, compared to $1.49 in the year-ago quarter. The current stock performance of Comerica shows a 52-week-high of $102.09 and a 52-week-low of $63.07. Moreover, at the end of the last trading period, the closing price was at $90.43.
According to JP Morgan, the prior rating for Vertiv Holdings Co (NYSE:VRT) was changed from Neutral to Overweight. For the fourth quarter, Vertiv Holdings had an EPS of $0.04, compared to year-ago quarter EPS of $0.33. At the moment, the stock has a 52-week-high of $28.80 and a 52-week-low of $9.59. Vertiv Holdings closed at $14.00 at the end of the last trading period.
According to Credit Suisse, the prior rating for Tellurian Inc (AMEX:TELL) was changed from Neutral to Outperform. Tellurian earned $0.09 in the fourth quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $5.94 and a 52-week-low of $1.62. Tellurian closed at $5.30 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
According to JonesTrading, the prior rating for Silverback Therapeutics Inc (NASDAQ:SBTX) was changed from Buy to Hold. In the fourth quarter, Silverback Therapeutics showed an EPS of $0.67, compared to $1.37 from the year-ago quarter. The stock has a 52-week-high of $46.55 and a 52-week-low of $3.36. At the end of the last trading period, Silverback Therapeutics closed at $3.51.
Baird downgraded the previous rating for Walgreens Boots Alliance Inc (NASDAQ:WBA) from Outperform to Neutral. For the second quarter, Walgreens Boots Alliance had an EPS of $1.59, compared to year-ago quarter EPS of $1.26. The stock has a 52-week-high of $57.05 and a 52-week-low of $43.62. At the end of the last trading period, Walgreens Boots Alliance closed at $44.77.
According to Truist Securities, the prior rating for Science Applications International Corp (NYSE:SAIC) was changed from Buy to Hold. In the fourth quarter, Science Applications Intl showed an EPS of $1.50, compared to $1.67 from the year-ago quarter. The stock has a 52-week-high of $96.50 and a 52-week-low of $78.10. At the end of the last trading period, Science Applications Intl closed at $92.17.
For Qorvo Inc (NASDAQ:QRVO), KGI Securities downgraded the previous rating of Outperform to Neutral. For the third quarter, Qorvo had an EPS of $2.98, compared to year-ago quarter EPS of $3.08. The current stock performance of Qorvo shows a 52-week-high of $201.68 and a 52-week-low of $117.03. Moreover, at the end of the last trading period, the closing price was at $124.10.
According to SMBC Nikko, the prior rating for Orchard Therapeutics PLC (NASDAQ:ORTX) was changed from Outperform to Neutral. Orchard Therapeutics earned $0.29 in the fourth quarter, compared to $0.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $7.47 and a 52-week-low of $0.68. Orchard Therapeutics closed at $0.71 at the end of the last trading period.
According to SVB Leerink, the prior rating for Silverback Therapeutics Inc (NASDAQ:SBTX) was changed from Outperform to Market Perform. In the fourth quarter, Silverback Therapeutics showed an EPS of $0.67, compared to $1.37 from the year-ago quarter. The current stock performance of Silverback Therapeutics shows a 52-week-high of $46.55 and a 52-week-low of $3.36. Moreover, at the end of the last trading period, the closing price was at $3.51.
According to Barclays, the prior rating for Urban Outfitters Inc (NASDAQ:URBN) was changed from Overweight to Equal-Weight. In the fourth quarter, Urban Outfitters showed an EPS of $0.41, compared to $0.30 from the year-ago quarter. The current stock performance of Urban Outfitters shows a 52-week-high of $42.10 and a 52-week-low of $23.94. Moreover, at the end of the last trading period, the closing price was at $25.11.
Barclays downgraded the previous rating for American Eagle Outfitters Inc (NYSE:AEO) from Overweight to Equal-Weight. American Eagle Outfitters earned $0.35 in the fourth quarter, compared to $0.39 in the year-ago quarter. The stock has a 52-week-high of $38.99 and a 52-week-low of $16.50. At the end of the last trading period, American Eagle Outfitters closed at $16.80.
For Gap Inc (NYSE:GPS), Barclays downgraded the previous rating of Equal-Weight to Underweight. In the fourth quarter, Gap showed an EPS of $0.02, compared to $0.28 from the year-ago quarter. The current stock performance of Gap shows a 52-week-high of $37.63 and a 52-week-low of $13.12. Moreover, at the end of the last trading period, the closing price was at $14.08.
Barclays downgraded the previous rating for Wayfair Inc (NYSE:W) from Equal-Weight to Underweight. Wayfair earned $0.92 in the fourth quarter, compared to $1.24 in the year-ago quarter. At the moment, the stock has a 52-week-high of $343.80 and a 52-week-low of $100.57. Wayfair closed at $110.78 at the end of the last trading period.
According to HC Wainwright & Co., the prior rating for Silverback Therapeutics Inc (NASDAQ:SBTX) was changed from Buy to Neutral. In the fourth quarter, Silverback Therapeutics showed an EPS of $0.67, compared to $1.37 from the year-ago quarter. The stock has a 52-week-high of $46.55 and a 52-week-low of $3.36. At the end of the last trading period, Silverback Therapeutics closed at $3.51.
For Blend Labs Inc (NYSE:BLND), Canaccord Genuity downgraded the previous rating of Buy to Hold. At the moment, the stock has a 52-week-high of $21.04 and a 52-week-low of $5.67. Blend Labs closed at $5.70 at the end of the last trading period.
Wells Fargo downgraded the previous rating for Blend Labs Inc (NYSE:BLND) from Overweight to Equal-Weight. The stock has a 52-week-high of $21.04 and a 52-week-low of $5.67. At the end of the last trading period, Blend Labs closed at $5.70.
Stifel downgraded the previous rating for Silverback Therapeutics Inc (NASDAQ:SBTX) from Buy to Hold. For the fourth quarter, Silverback Therapeutics had an EPS of $0.67, compared to year-ago quarter EPS of $1.37. The current stock performance of Silverback Therapeutics shows a 52-week-high of $46.55 and a 52-week-low of $3.36. Moreover, at the end of the last trading period, the closing price was at $3.51.
For CommScope Holding Co Inc (NASDAQ:COMM), Goldman Sachs downgraded the previous rating of Buy to Neutral. CommScope Hldg Co earned $0.31 in the fourth quarter, compared to $0.59 in the year-ago quarter. The stock has a 52-week-high of $22.18 and a 52-week-low of $6.67. At the end of the last trading period, CommScope Hldg Co closed at $7.88.
According to Goldman Sachs, the prior rating for Dell Technologies Inc (NYSE:DELL) was changed from Buy to Neutral. Dell Technologies earned $1.72 in the fourth quarter, compared to $2.70 in the year-ago quarter. The current stock performance of Dell Technologies shows a 52-week-high of $115.00 and a 52-week-low of $48.98. Moreover, at the end of the last trading period, the closing price was at $50.19.
For Ellington Residential Mortgage REIT (NYSE:EARN), JMP Securities downgraded the previous rating of Market Outperform to Market Perform. For the fourth quarter, Ellington Residential had an EPS of $0.28, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of $13.92 and a 52-week-low of $8.90. Ellington Residential closed at $10.09 at the end of the last trading period.
Stifel downgraded the previous rating for Poshmark Inc (NASDAQ:POSH) from Buy to Hold. For the fourth quarter, Poshmark had an EPS of $0.19, compared to year-ago quarter EPS of $0.05. The current stock performance of Poshmark shows a 52-week-high of $52.39 and a 52-week-low of $10.65. Moreover, at the end of the last trading period, the closing price was at $12.66.
JP Morgan downgraded the previous rating for BankUnited Inc (NYSE:BKU) from Overweight to Neutral. For the fourth quarter, BankUnited had an EPS of $1.41, compared to year-ago quarter EPS of $0.89. The stock has a 52-week-high of $49.55 and a 52-week-low of $37.08. At the end of the last trading period, BankUnited closed at $43.96.
For Amylyx Pharmaceuticals Inc (NASDAQ:AMLX), Goldman Sachs downgraded the previous rating of Buy to Neutral. At the moment, the stock has a 52-week-high of $33.41 and a 52-week-low of $10.49. Amylyx Pharmaceuticals closed at $12.85 at the end of the last trading period.
According to Credit Suisse, the prior rating for First American Financial Corp (NYSE:FAF) was changed from Outperform to Neutral. First American Financial earned $2.28 in the fourth quarter, compared to $2.11 in the year-ago quarter. The current stock performance of First American Financial shows a 52-week-high of $81.54 and a 52-week-low of $56.40. Moreover, at the end of the last trading period, the closing price was at $64.82.
For NextDecade Corp (NASDAQ:NEXT), Credit Suisse downgraded the previous rating of Outperform to Neutral. For the fourth quarter, NextDecade had an EPS of $0.11, compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of $7.33 and a 52-week-low of $1.83. NextDecade closed at $6.62 at the end of the last trading period.
According to JP Morgan, the prior rating for UniFirst Corp (NYSE:UNF) was changed from Neutral to Underweight. In the second quarter, UniFirst showed an EPS of $1.24, compared to $1.71 from the year-ago quarter. The stock has a 52-week-high of $242.79 and a 52-week-low of $165.52. At the end of the last trading period, UniFirst closed at $184.28.
Piper Sandler downgraded the previous rating for Blend Labs Inc (NYSE:BLND) from Overweight to Neutral. The current stock performance of Blend Labs shows a 52-week-high of $21.04 and a 52-week-low of $5.67. Moreover, at the end of the last trading period, the closing price was at $5.70.
See all analyst ratings downgrades.
Initiations
Summit Insights Group initiated coverage on Check Point Software Technologies Ltd (NASDAQ:CHKP) with a Buy rating. The price target for Check Point Software is set to $160.00. In the fourth quarter, Check Point Software showed an EPS of $2.25, compared to $2.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $149.62 and a 52-week-low of $107.85. Check Point Software closed at $138.26 at the end of the last trading period.
With a Neutral rating, SMBC Nikko initiated coverage on Snowflake Inc (NYSE:SNOW). The price target seems to have been set at $253.00 for Snowflake. In the fourth quarter, Snowflake showed an EPS of $0.12, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $405.00 and a 52-week-low of $164.29. Snowflake closed at $229.13 at the end of the last trading period.
Raymond James initiated coverage on MVB Financial Corp (NASDAQ:MVBF) with a Strong Buy rating. The price target for MVB Financial is set to $64.00. MVB Financial earned $0.77 in the fourth quarter, compared to $0.97 in the year-ago quarter. The stock has a 52-week-high of $45.94 and a 52-week-low of $32.84. At the end of the last trading period, MVB Financial closed at $41.50.
Truist Securities initiated coverage on Vectrus Inc (NYSE:VEC) with a Buy rating. The price target for Vectrus is set to $65.00. Vectrus earned $0.90 in the fourth quarter, compared to $1.18 in the year-ago quarter. The current stock performance of Vectrus shows a 52-week-high of $55.38 and a 52-week-low of $33.65. Moreover, at the end of the last trading period, the closing price was at $35.86.
With a Neutral rating, Daiwa Capital initiated coverage on Oracle Corp (NYSE:ORCL). The price target seems to have been set at $87.00 for Oracle. Oracle earned $1.13 in the third quarter, compared to $1.16 in the year-ago quarter. The current stock performance of Oracle shows a 52-week-high of $106.34 and a 52-week-low of $69.91. Moreover, at the end of the last trading period, the closing price was at $82.73.
Goldman Sachs initiated coverage on MSCI Inc (NYSE:MSCI) with a Neutral rating. The price target for MSCI is set to $553.00. MSCI earned $2.51 in the fourth quarter, compared to $1.96 in the year-ago quarter. At the moment, the stock has a 52-week-high of $679.85 and a 52-week-low of $416.64. MSCI closed at $502.88 at the end of the last trading period.
Morgan Stanley initiated coverage on Agree Realty Corp (NYSE:ADC) with an Overweight rating. The price target for Agree Realty is set to $75.00. For the fourth quarter, Agree Realty had an EPS of $0.91, compared to year-ago quarter EPS of $0.83. The stock has a 52-week-high of $75.95 and a 52-week-low of $61.62. At the end of the last trading period, Agree Realty closed at $66.36.
Stephens & Co. initiated coverage on Upstart Holdings Inc (NASDAQ:UPST) with a Equal-Weight rating. The price target for Upstart Hldgs is set to $124.00. For the fourth quarter, Upstart Hldgs had an EPS of $0.89, compared to year-ago quarter EPS of $0.07. The current stock performance of Upstart Hldgs shows a 52-week-high of $401.49 and a 52-week-low of $75.15. Moreover, at the end of the last trading period, the closing price was at $109.09.
Oppenheimer initiated coverage on Rain Therapeutics Inc (NASDAQ:RAIN) with an Outperform rating. The price target for Rain Therapeutics is set to $15.00. The current stock performance of Rain Therapeutics shows a 52-week-high of $23.90 and a 52-week-low of $5.00. Moreover, at the end of the last trading period, the closing price was at $5.07.
Oppenheimer initiated coverage on Immuneering Corp (NASDAQ:IMRX) with an Outperform rating. The price target for Immuneering is set to $25.00. For the fourth quarter, Immuneering had an EPS of $0.42, compared to year-ago quarter EPS of $1.18. The stock has a 52-week-high of $33.99 and a 52-week-low of $6.27. At the end of the last trading period, Immuneering closed at $6.47.
